Log in to save to my catalogue

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e93b01058ae9422ebd8c558102f65c5a

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects

About this item

Full title

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects

Publisher

United States: Public Library of Science

Journal title

PLoS neglected tropical diseases, 2025-01, Vol.19 (1), p.e0012735

Language

English

Formats

Publication information

Publisher

United States: Public Library of Science

More information

Scope and Contents

Contents

Leishmaniasis, a neglected tropical disease caused by
Leishmania
parasites, continues to pose global health challenges. Current treatments face issues like resistance, safety, efficacy, and cost. This review covers the discovery, mechanisms of action, clinical applications, and limitations of key antileishmanial agents: pentavalent antimonial...

Alternative Titles

Full title

Progress in antileishmanial drugs: Mechanisms, challenges, and prospects

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_e93b01058ae9422ebd8c558102f65c5a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_e93b01058ae9422ebd8c558102f65c5a

Other Identifiers

ISSN

1935-2735,1935-2727

E-ISSN

1935-2735

DOI

10.1371/journal.pntd.0012735

How to access this item